logo

For the Inventor, By the Inventor

Ashiya, Japan

Tomomi Makino

This inventor holds 7 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Nippon Shokubai Co., Ltd., Hitachi Cable, Inc.. Active years: 2002-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomomi Makino. Retrieved from https://idiyas.com/inventor/tomomi-makino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 42.9

 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Ashiya, JP (2002 - 2012)
  • Suita, JP (2013 - 2022)
  • Osaka, JP (2022)

Company Filing History:

goldMedal7 out of 1,335 
 
Nippon Shokubai Co., Ltd.
 patents
silverMedal2 out of 836 
 
Hitachi Cable, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2002-2022

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 11447743 - Cell culture substrate comprising fluorine-containing polymer on its surface (2022-09-20),
2. 11213550 - Cell preparation for treating cartilage tissue-related disorder (2022-01-04),
3. 8470917 - Production method of polyimide solution and fluorinated polyimide solution (2013-06-25),
4. 8218923 - Optical waveguide substrate with optical fiber fixation groove, process for its production, stamps for use in this production process, and opto-electronic hybrid integrated module including said optical waveguide substrate (2012-07-10),
5. 8155493 - Flexible optical waveguide and process for its production (2012-04-10),
6. 7409139 - Halogenated polyamide acid composition and its applications (2008-08-05),
7. 6417306 - Transparent heat-resistant resin and production process therefor (2002-07-09),

Title: Tomomi Makino: Innovator in Cell Culture Technology

Introduction

Tomomi Makino is a prominent inventor based in Ashiya, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of advanced cell culture substrates. With a total of 7 patents to his name, Makino's work is paving the way for innovative solutions in tissue engineering.

Latest Patents

One of his latest inventions is a cell culture substrate comprising a fluorine-containing polymer on its surface. This invention provides a substrate that enables three-dimensional tissue culture, which is crucial for various biomedical applications. The substrate features a surface that includes a resin composition made of a fluorine-containing polymer, exhibiting an oxygen gas permeability of 219 cm(STP)/(m·24 h·atm) or higher. This allows for the effective formation of three-dimensional tissue via cell culture.

Another notable patent is for a cell preparation aimed at treating cartilage tissue-related disorders. This invention offers a spheroid-containing cell preparation that demonstrates a high therapeutic effect for such disorders. The preparation contains cultured mesenchymal stem cells as an effective ingredient, making it a promising candidate for treatment.

Career Highlights

Throughout his career, Tomomi Makino has worked with reputable companies, including Nippon Shokubai Co., Ltd. and Hitachi Cable, Inc. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.

Collaborations

Makino has collaborated with notable colleagues, including Kozo Tajiri and Takami Ushiwata. These partnerships have further enhanced his research and development efforts in the biotechnology sector.

Conclusion

Tomomi Makino's innovative work in cell culture technology and his impressive portfolio of patents highlight his significant impact on the field. His contributions are essential for advancing therapeutic solutions in tissue engineering and regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…